{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/AMRX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T19:02:22.815Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":1635,"canonical_name":"Amneal Pharmaceuticals, Inc.","cik":"0001723128","uei":null,"lei":null,"duns":null,"ticker":"AMRX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"fda":2,"sec":37},"count":39,"timeline":[{"ts":"2026-09-08","kind":"fda.recall","reporter":"Amneal Pharmaceuticals, LLC","title":"Class II","security_title":"Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08907, NDC 69238-2452-3.","excerpt":"Defective Container; packets were found to be either empty or partially full.","accession_number":"D-0873-2026","status":"Ongoing","product_type":"drug","importance":60},{"ts":"2026-09-03","kind":"sec.filing","form_type":"S-3ASR","title":"S-3ASR — Amneal Pharmaceuticals, Inc. — 2026-09-03","url_slug":"/sec/cik-0001723128/s-3asr/0001140361-26-035617","accession_number":"0001140361-26-035617","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"4","title":"4 — Amneal Pharmaceuticals, Inc. — 2026-08-14","url_slug":"/sec/cik-0001723128/4/0001628280-26-057147","accession_number":"0001628280-26-057147","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"144","title":"144 — Amneal Pharmaceuticals, Inc. — 2026-08-13","url_slug":"/sec/cik-0001723128/144/0001628280-26-056733","accession_number":"0001628280-26-056733","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"4","title":"4 — Amneal Pharmaceuticals, Inc. — 2026-08-13","url_slug":"/sec/cik-0001723128/4/0001628280-26-056754","accession_number":"0001628280-26-056754","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"4","title":"4 — Amneal Pharmaceuticals, Inc. — 2026-08-13","url_slug":"/sec/cik-0001723128/4/0001628280-26-056757","accession_number":"0001628280-26-056757","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"SCHEDULE 13D/A","title":"SCHEDULE 13D/A — Amneal Pharmaceuticals, Inc. — 2026-08-12","url_slug":"/sec/cik-0001723128/schedule-13d-a/0000898432-26-000652","accession_number":"0000898432-26-000652","importance":70},{"ts":"2026-08-12","kind":"sec.filing","form_type":"SCHEDULE 13D/A","title":"SCHEDULE 13D/A — Amneal Pharmaceuticals, Inc. — 2026-08-12","url_slug":"/sec/cik-0001723128/schedule-13d-a/0000898432-26-000653","accession_number":"0000898432-26-000653","importance":70},{"ts":"2026-08-12","kind":"sec.filing","form_type":"SCHEDULE 13D/A","title":"SCHEDULE 13D/A — Amneal Pharmaceuticals, Inc. — 2026-08-12","url_slug":"/sec/cik-0001723128/schedule-13d-a/0000898432-26-000654","accession_number":"0000898432-26-000654","importance":70},{"ts":"2026-08-12","kind":"sec.filing","form_type":"144","title":"144 — Amneal Pharmaceuticals, Inc. — 2026-08-12","url_slug":"/sec/cik-0001723128/144/0001628280-26-056196","accession_number":"0001628280-26-056196","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"144","title":"144 — Amneal Pharmaceuticals, Inc. — 2026-08-12","url_slug":"/sec/cik-0001723128/144/0001628280-26-056220","accession_number":"0001628280-26-056220","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"4","title":"4 — Amneal Pharmaceuticals, Inc. — 2026-08-12","url_slug":"/sec/cik-0001723128/4/0000898432-26-000655","accession_number":"0000898432-26-000655","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"4","title":"4 — Amneal Pharmaceuticals, Inc. — 2026-08-12","url_slug":"/sec/cik-0001723128/4/0001628280-26-056285","accession_number":"0001628280-26-056285","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"4","title":"4 — Amneal Pharmaceuticals, Inc. — 2026-08-12","url_slug":"/sec/cik-0001723128/4/0001628280-26-056288","accession_number":"0001628280-26-056288","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"4","title":"4 — Amneal Pharmaceuticals, Inc. — 2026-08-12","url_slug":"/sec/cik-0001723128/4/0001628280-26-056297","accession_number":"0001628280-26-056297","importance":30},{"ts":"2026-08-11","kind":"sec.form144","reporter":"BUCHI J KEVIN","title":"Director","shares":168573,"usd_value":2917998,"security_title":"Common","approx_sale_date":"2026-08-11","accession_number":"0001949846-26-000494","importance":40.5835996},{"ts":"2026-08-10","kind":"sec.filing","form_type":"8-K","title":"8-K — Amneal Pharmaceuticals, Inc. — 2026-08-10","url_slug":"/sec/cik-0001723128/8-k/0001140361-26-032014","accession_number":"0001140361-26-032014","importance":35},{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Amneal Pharmaceuticals, Inc. — 2026-08-06","url_slug":"/sec/cik-0001723128/10-q/0001723128-26-000031","accession_number":"0001723128-26-000031","importance":45},{"ts":"2026-08-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Amneal Pharmaceuticals, Inc. — 2026-08-03","url_slug":"/sec/cik-0001723128/8-k/0001628280-26-051900","accession_number":"0001628280-26-051900","importance":35},{"ts":"2026-07-31","kind":"sec.filing","form_type":"8-K","title":"8-K — Amneal Pharmaceuticals, Inc. — 2026-07-31","url_slug":"/sec/cik-0001723128/8-k/0001140361-26-030491","accession_number":"0001140361-26-030491","importance":35},{"ts":"2026-07-30","kind":"sec.filing","form_type":"8-K","title":"8-K — Amneal Pharmaceuticals, Inc. — 2026-07-30","url_slug":"/sec/cik-0001723128/8-k/0001723128-26-000025","accession_number":"0001723128-26-000025","importance":35},{"ts":"2026-07-30","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Amneal Pharmaceuticals, Inc. — 2026-07-30","url_slug":"/sec/cik-0001723128/defa14a/0001140361-26-030141","accession_number":"0001140361-26-030141","importance":30},{"ts":"2026-06-29","kind":"sec.filing","form_type":"DEFM14A","title":"DEFM14A — Amneal Pharmaceuticals, Inc. — 2026-06-29","url_slug":"/sec/cik-0001723128/defm14a/0001140361-26-026611","accession_number":"0001140361-26-026611","importance":30},{"ts":"2026-06-03","kind":"fda.recall","reporter":"Amneal Pharmaceuticals, LLC","title":"Class III","security_title":"Primidone Tablets, USP, 50 mg, 100 Tablets per Bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA.  Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807.  NDC: 53746-544-01","excerpt":"Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.","accession_number":"D-0585-2026","status":"Ongoing","product_type":"drug","importance":25},{"ts":"2026-05-12","kind":"sec.filing","form_type":"4","title":"4 — Amneal Pharmaceuticals, Inc. — 2026-05-12","url_slug":"/sec/cik-0001723128/4/0001628280-26-034106","accession_number":"0001628280-26-034106","importance":30},{"ts":"2026-05-11","kind":"sec.insider.s","reporter":"Autor Deborah M.","title":null,"shares":34819,"price_per_share":12.94,"usd_value":450558,"security_title":"Class A Common Stock","importance":35.45055786},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Amneal Pharmaceuticals, Inc. — 2026-05-08","url_slug":"/sec/cik-0001723128/4/0001628280-26-032911","accession_number":"0001628280-26-032911","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Amneal Pharmaceuticals, Inc. — 2026-05-08","url_slug":"/sec/cik-0001723128/4/0001628280-26-032922","accession_number":"0001628280-26-032922","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Amneal Pharmaceuticals, Inc. — 2026-05-08","url_slug":"/sec/cik-0001723128/4/0001628280-26-032924","accession_number":"0001628280-26-032924","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Amneal Pharmaceuticals, Inc. — 2026-05-08","url_slug":"/sec/cik-0001723128/4/0001628280-26-032925","accession_number":"0001628280-26-032925","importance":30},{"ts":"2026-05-07","kind":"sec.insider.m","reporter":"MEISTER PAUL M","title":null,"shares":48747,"price_per_share":null,"usd_value":0,"security_title":"Class A Common Stock","importance":15},{"ts":"2026-05-07","kind":"sec.insider.m","reporter":"BUCHI J KEVIN","title":null,"shares":34819,"price_per_share":null,"usd_value":0,"security_title":"Class A Common Stock","importance":15},{"ts":"2026-05-07","kind":"sec.insider.m","reporter":"Nark Ted C","title":null,"shares":34819,"price_per_share":null,"usd_value":0,"security_title":"Class A Common Stock","importance":15},{"ts":"2026-05-07","kind":"sec.insider.m","reporter":"Yanai Shlomo","title":null,"shares":34819,"price_per_share":null,"usd_value":0,"security_title":"Class A Common Stock","importance":15},{"ts":"2026-05-07","kind":"sec.insider.m","reporter":"Kiely John","title":null,"shares":34819,"price_per_share":null,"usd_value":0,"security_title":"Class A Common Stock","importance":15},{"ts":"2026-05-07","kind":"sec.insider.m","reporter":"Patel Gautam","title":null,"shares":34819,"price_per_share":null,"usd_value":0,"security_title":"Class A Common Stock","importance":15},{"ts":"2026-05-07","kind":"sec.insider.m","reporter":"Autor Deborah M.","title":null,"shares":34819,"price_per_share":null,"usd_value":0,"security_title":"Class A Common Stock","importance":15},{"ts":"2026-05-07","kind":"sec.insider.m","reporter":"George Jeffrey P.","title":null,"shares":34819,"price_per_share":null,"usd_value":0,"security_title":"Class A Common Stock","importance":15},{"ts":"2026-04-27","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Amneal Pharmaceuticals, Inc. — 2026-04-27","url_slug":"/sec/cik-0001723128/schedule-13g/0002012383-26-001669","accession_number":"0002012383-26-001669","importance":55}]}